|
|
|
Volumn 174, Issue 1, 1996, Pages 1-22
|
|
Pharmacological basis for duration of effect: Formoterol and salmeterol versus short-acting β2-adrenoceptor agonists
|
|
Author keywords
2 adrenoceptor agonists; Airway smooth muscle relaxation; Bronchodilator; Duration of action; Exosite; Formoterol; Microkinetic diffusion; Salmeterol
|
|
Indexed keywords
BETA 2 ADRENERGIC RECEPTOR;
BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT;
BRONCHODILATING AGENT;
FENOTEROL;
FORMOTEROL;
FORMOTEROL FUMARATE;
ISOPRENALINE;
LONG ACTING DRUG;
PROPRANOLOL;
SALBUTAMOL;
SALMETEROL;
SALMETEROL XINAFOATE;
BETA ADRENERGIC STIMULATION;
BRONCHODILATATION;
DOSE RESPONSE;
DRUG MECHANISM;
DRUG POTENCY;
DRUG RECEPTOR BINDING;
DRUG SELECTIVITY;
DRUG SOLUBILITY;
HUMAN;
LIPOPHILICITY;
NONHUMAN;
PRIORITY JOURNAL;
RECEPTOR AFFINITY;
REVIEW;
ADRENERGIC BETA-AGONISTS;
ALBUTEROL;
ANIMALS;
BRONCHI;
BRONCHODILATOR AGENTS;
ETHANOLAMINES;
HUMANS;
MUSCLE RELAXATION;
MUSCLE, SMOOTH;
RECEPTORS, ADRENERGIC, BETA-2;
TIME FACTORS;
|
|
EID: 0030047987
PISSN: 03412040
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
|
Times cited : (26)
|
|
References (8)
|
